相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long non coding RNA SLC26A4-AS1 exerts antiangiogenic effects in human glioma by upregulating NPTX1 via NFKB1 transcriptional factor
Haijun Li et al.
FEBS JOURNAL (2021)
Patient-derived glioblastoma stem cells transfer mitochondria through tunneling nanotubes in tumor organoids
Giulia Pinto et al.
BIOCHEMICAL JOURNAL (2021)
Cancer Stem Cells-Key Players in Tumor Relapse
Monica Marzagalli et al.
CANCERS (2021)
Beyond the Warburg Effect: Oxidative and Glycolytic Phenotypes Coexist within the Metabolic Heterogeneity of Glioblastoma
Tomas Duraj et al.
CELLS (2021)
Unlocking the Power of Exosomes for Crossing Biological Barriers in Drug Delivery
Rebekah Omarkhail Elliott et al.
PHARMACEUTICS (2021)
Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation
Karthik Dhatchinamoorthy et al.
FRONTIERS IN IMMUNOLOGY (2021)
Neuronavigation-guided focused ultrasound for transcranial blood-brain barrier opening and immunostimulation in brain tumors
Ko-Ting Chen et al.
SCIENCE ADVANCES (2021)
The Many Facets of Therapy Resistance and Tumor Recurrence in Glioblastoma
Anshika Goenka et al.
CELLS (2021)
An insight into the structure of 5-spiro aromatic derivatives of imidazolidine-2,4-dione, a new group of very potent inhibitors of tumor multidrug resistance in T-lymphoma cells
Ewa Zeslawska et al.
BIOORGANIC CHEMISTRY (2021)
Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion
Ester Gangoso et al.
CELL (2021)
A Composite Nanosystem as a Potential Tool for the Local Treatment of Glioblastoma: Chitosan-Coated Solid Lipid Nanoparticles Embedded in Electrospun Nanofibers
Barbara Vigani et al.
POLYMERS (2021)
TLR4 expression and functionality are downregulated in glioblastoma cells and in tumor-associated macrophages: A new mechanism of immune evasion?
L. L. P. da Cruz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2021)
Hypoxic Glioma Stem Cell-Derived Exosomes Containing Linc01060 Promote Progression of Glioma by Regulating the MZE1/c-Myc/HIF1α Axis
Junjun Li et al.
CANCER RESEARCH (2021)
The blood-brain barrier: Physiology and strategies for drug delivery
Rucha Pandit et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Bevacizumab versus alkylating chemotherapy in recurrent glioblastoma
Katharina Seystahl et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
O6-Methylguanine-DNA Methyltransferase (MGMT): Challenges and New Opportunities in Glioma Chemotherapy
Wei Yu et al.
FRONTIERS IN ONCOLOGY (2020)
MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-a, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial
Debashis Sarker et al.
CLINICAL CANCER RESEARCH (2020)
The Interactions Between Cancer Stem Cells and the Innate Interferon Signaling Pathway
Laura Martin-Hijano et al.
FRONTIERS IN IMMUNOLOGY (2020)
Perhexiline Demonstrates FYN-mediated Antitumor Activity in Glioblastoma
Shiva Kant et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Mechanisms and therapeutic implications of hypermutation in gliomas
Mehdi Touat et al.
NATURE (2020)
Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications
Young Hun Chung et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Irisin, an exercise myokine, potently suppresses tumor proliferation, invasion, and growth in glioma
Chiun-Wei Huang et al.
FASEB JOURNAL (2020)
Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies
Paul Hoppenz et al.
FRONTIERS IN CHEMISTRY (2020)
The Role of RNA and DNA Aptamers in Glioblastoma Diagnosis and Therapy: A Systematic Review of the Literature
Silvia Nuzzo et al.
CANCERS (2020)
Targeted Brain Tumor Therapy by Inhibiting the MDM2 Oncogene: In Vitro and In Vivo Antitumor Activity and Mechanism of Action
Surendra R. Punganuru et al.
CELLS (2020)
Designing peptide nanoparticles for efficient brain delivery
Aroa Duro-Castano et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Molecular analyses of glioblastoma stem-like cells and glioblastoma tissue
Marco Wallenborn et al.
PLOS ONE (2020)
Single-cell RNA-seq reveals that glioblastoma recapitulates a normal neurodevelopmental hierarchy
Charles P. Couturier et al.
NATURE COMMUNICATIONS (2020)
Glioma-initiating cells at tumor edge gain signals from tumor core cells to promote their malignancy
Soniya Bastola et al.
NATURE COMMUNICATIONS (2020)
Aptamers: Novel Therapeutics and Potential Role in Neuro-Oncology
Paola Amero et al.
CANCERS (2020)
The Resistance Mechanisms of Lung Cancer Immunotherapy
Fen Wang et al.
FRONTIERS IN ONCOLOGY (2020)
Pharmacokinetic Principles and Their Application to Central Nervous System Tumors
Joelle P. Straehla et al.
PHARMACEUTICS (2020)
Treatment Progress of Immune Checkpoint Blockade Therapy for Glioblastoma
Na Zhang et al.
FRONTIERS IN IMMUNOLOGY (2020)
Co-Delivery of CPT-11 and Panobinostat with Anti-GD2 Antibody Conjugated Immunoliposomes for Targeted Combination Chemotherapy
Gils Jose et al.
CANCERS (2020)
Cell- mediated immune resistance in cancer
Yuhao Wang et al.
CANCER DRUG RESISTANCE (2020)
The landscape of the mesenchymal signature in brain tumours
Jinan Behnan et al.
BRAIN (2019)
Proteins of the Wnt signaling pathway as targets for the regulation of CD133+ cancer stem cells in glioblastoma
Valery Shevchenko et al.
ONCOLOGY REPORTS (2019)
Role of Notch Signaling Pathway in Glioblastoma Pathogenesis
Riccardo Bazzoni et al.
CANCERS (2019)
Temozolomide Induced Hypermutation in Glioma: Evolutionary Mechanisms and Therapeutic Opportunities
Paul Daniel et al.
FRONTIERS IN ONCOLOGY (2019)
Targeting JUN, CEBPB, and HDAC3: A Novel Strategy to Overcome Drug Resistance in Hypoxic Glioblastoma
Yixing Gao et al.
FRONTIERS IN ONCOLOGY (2019)
Theranostic Nanoparticles for RNA-Based Cancer Treatment
Richard A. Revia et al.
ACCOUNTS OF CHEMICAL RESEARCH (2019)
Eupatilin inhibits glioma proliferation, migration, and invasion by arresting cell cycle at G1/S phase and disrupting the cytoskeletal structure
Xiaowei Fei et al.
CANCER MANAGEMENT AND RESEARCH (2019)
CAR T cells for brain tumors: Lessons learned and road ahead
David Akhavan et al.
IMMUNOLOGICAL REVIEWS (2019)
MET in glioma: signaling pathways and targeted therapies
Fangling Cheng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Cell Adhesion Molecules and Their Roles and Regulation in the Immune and Tumor Microenvironment
Heidi Harjunpaa et al.
FRONTIERS IN IMMUNOLOGY (2019)
Experimental models and tools to tackle glioblastoma
Faye L. Robertson et al.
DISEASE MODELS & MECHANISMS (2019)
Nuclear FAM289-Galectin-1 interaction controls FAM289-mediated tumor promotion in malignant glioma
Xing Rong Guo et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
miR-140 targeting CTSB signaling suppresses the mesenchymal transition and enhances temozolomide cytotoxicity in glioblastoma multiforme
Kuo-Hao Ho et al.
PHARMACOLOGICAL RESEARCH (2019)
MiR-181b-5p modulates chemosensitivity of glioma cells to temozolomide by targeting Bcl-2
Xiyue Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Stemness, Pluripotentiality, and Wnt Antagonism: sFRP4, a Wnt antagonist Mediates Pluripotency and Stemness in Glioblastoma
Gurubharathi Bhuvanalakshmi et al.
CANCERS (2019)
A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment
Da Wang et al.
DRUG DELIVERY (2019)
CNS: Not an immunoprivilaged site anymore but a virtual secondary lymphoid organ
Neema Negi et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2018)
Targeting epidermal growth factor receptor co-dependent signaling pathways in glioblastoma
Feng Liu et al.
WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2018)
Improved effects of honokiol on temozolomide-induced autophagy and apoptosis of drug-sensitive and -tolerant glioma cells
Chung-Ching Chio et al.
BMC CANCER (2018)
Inhibition of the PI3K but not the MEK/ERK pathway sensitizes human glioma cells to alkylating drugs
Bodo Haas et al.
CANCER CELL INTERNATIONAL (2018)
miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway
Hong Li et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Drug Delivery Nanosystems for the Localized Treatment of Glioblastoma Multiforme
L. Nam et al.
MATERIALS (2018)
A Distinct DNA Methylation Shift in a Subset of Glioma CpG Island Methylator Phenotypes during Tumor Recurrence
Camila Ferreira de Souza et al.
CELL REPORTS (2018)
Chemo-resistance of A172 glioblastoma cells is controlled by miR-1271-regulated Bcl-2
Li Yang et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate
Qi Chen et al.
MBIO (2018)
Newcastle disease virus enhances the growth-inhibiting and proapoptotic effects of temozolomide on glioblastoma cells in vitro and in vivo
Yang Bai et al.
SCIENTIFIC REPORTS (2018)
Emerging Technologies for Delivery of Biotherapeutics and Gene Therapy Across the Blood-Brain Barrier
Danica B. Stanimirovic et al.
BIODRUGS (2018)
Roles of the immune system in cancer: from tumor initiation to metastatic progression
Hugo Gonzalez et al.
GENES & DEVELOPMENT (2018)
NQO1 Is Regulated by PTEN in Glioblastoma, Mediating Cell Proliferation and Oxidative Stress
Shilin Luo et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide- responsive and - resistant glioblastoma
Tara A. Barone et al.
NEURO-ONCOLOGY (2017)
RNA processing as an alternative route to attack glioblastoma
Fabiana Marcelino Meliso et al.
HUMAN GENETICS (2017)
MicroRNA-132 induces temozolomide resistance and promotes the formation of cancer stem cell phenotypes by targeting tumor suppressor candidate 3 in glioblastoma
Zhen-Xiu Cheng et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)
Tumor microtubes convey resistance to surgical lesions and chemotherapy in gliomas
Sophie Weil et al.
NEURO-ONCOLOGY (2017)
The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of Revision
Takashi Komori
NEUROLOGIA MEDICO-CHIRURGICA (2017)
The CHAC1-inhibited Notch3 pathway is involved in temozolomide-induced glioma cytotoxicity
Peng-Hsu Chen et al.
NEUROPHARMACOLOGY (2017)
Sulforaphane-cysteine induces apoptosis by sustained activation of ERK1/2 and caspase 3 in human glioblastoma U373MG and U87MG cells
Sai Wu et al.
ONCOLOGY REPORTS (2017)
Salinomycin induces endoplasmic reticulum stress-mediated autophagy and apoptosis through generation of reactive oxygen species in human glioma U87MG cells
Sun-Nyoung Yu et al.
ONCOLOGY REPORTS (2017)
Verapamil augments carmustine- and irradiation-induced senescence in glioma cells by reducing intracellular reactive oxygen species and calcium ion levels
Seok Won Ham et al.
TUMOR BIOLOGY (2017)
miR-133a Promotes TRAIL Resistance in Glioblastoma via Suppressing Death Receptor 5 and Activating NF-κB Signaling
Shan-shan Wang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
Targeting Malignant Brain Tumors with Antibodies
Rok Razpotnik et al.
FRONTIERS IN IMMUNOLOGY (2017)
Role and Therapeutic Targeting of the HGF/MET Pathway in Glioblastoma
Nichola Cruickshanks et al.
CANCERS (2017)
The Damaging Effect of Passenger Mutations on Cancer Progression
Christopher D. McFarland et al.
CANCER RESEARCH (2017)
Anticancer strategies based on the metabolic profile of tumor cells: therapeutic targeting of the Warburg effect
Xi-sha Chen et al.
ACTA PHARMACOLOGICA SINICA (2016)
Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier
David S. Hersh et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
A malignant cellular network in gliomas: potential clinical implications
Matthias Osswald et al.
NEURO-ONCOLOGY (2016)
The Warburg Effect: How Does it Benefit Cancer Cells?
Maria V. Liberti et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
Glioblastoma: Overview of Disease and Treatment
Mary Elizabeth Davis
CLINICAL JOURNAL OF ONCOLOGY NURSING (2016)
Functional genomics analyses of RNA-binding proteins reveal the splicing regulator SNRPB as an oncogenic candidate in glioblastoma
Bruna R. Correa et al.
GENOME BIOLOGY (2016)
Tumor-specific delivery of BSH-3R for boron neutron capture therapy and positron emission tomography imaging in a mouse brain tumor model
Yoshiya Iguchi et al.
BIOMATERIALS (2015)
Cancer stem cells in glioblastoma
Justin D. Lathia et al.
GENES & DEVELOPMENT (2015)
The Role of Cytokines in Breast Cancer Development and Progression
Marcela Esquivel-Velazquez et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2015)
Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth
Wenchao Zhou et al.
NATURE CELL BIOLOGY (2015)
Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3′ Splice Site Selection through Use of a Different Branch Point
Rachel B. Darman et al.
CELL REPORTS (2015)
The acceleration of boron neutron capture therapy using multi-linked mercaptoundecahydrododecaborate (BSH) fused cell-penetrating peptide
Hiroyuki Michiue et al.
BIOMATERIALS (2014)
Therapeutic activation of macrophages and microglia to suppress brain tumor-initiating cells
Susobhan Sarkar et al.
NATURE NEUROSCIENCE (2014)
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Anoop P. Patel et al.
SCIENCE (2014)
Open questions for Alzheimer's disease immunotherapy
Todd E. Golde
ALZHEIMERS RESEARCH & THERAPY (2014)
Cell Plasticity and Heterogeneity in Cancer
Nemanja D. Marjanovic et al.
CLINICAL CHEMISTRY (2013)
Cancer stem cells: The challenges ahead
Jan Paul Medema
NATURE CELL BIOLOGY (2013)
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
Andrea Sottoriva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expression
Wei Zhang et al.
NEURO-ONCOLOGY (2012)
Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy
Mamta Wankhede et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2012)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Immunobiological Characterization of Cancer Stem Cells Isolated from Glioblastoma Patients
Tiziano Di Tomaso et al.
CLINICAL CANCER RESEARCH (2010)
Glioma cancer stem cells induce immunosuppressive macrophages/microglia
Adam Wu et al.
NEURO-ONCOLOGY (2010)
Structure and function of the blood-brain barrier
N. Joan Abbott et al.
NEUROBIOLOGY OF DISEASE (2010)
Convection-enhanced delivery for the treatment of brain tumors
Waldemar Debinski et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2009)
Antigen-Specific T-Cell Response from Dendritic Cell Vaccination Using Cancer Stem-Like Cell-Associated Antigens
Qijin Xu et al.
STEM CELLS (2009)
Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease
Leah R. Hanson et al.
BMC NEUROSCIENCE (2008)
Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2
A. Regina et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Strategies to advance translational research into brain barriers
Edward Neuwelt et al.
LANCET NEUROLOGY (2008)
The complex role of B7 molecules in tumor immunology
Barbara Seliger et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Blood-brain barrier transport of therapeutics via receptor-mediation
Angela R. Jones et al.
PHARMACEUTICAL RESEARCH (2007)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Analysis of gene expression and chemoresistance of CDI33+ cancer stem cells in glioblastoma
Gentao Liu et al.
MOLECULAR CANCER (2006)
Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas
Serena Pellegatta et al.
CANCER RESEARCH (2006)
An accelerated senescence response to radiation in wild-type p53 glioblastoma multiforme cells
Quincy A. Quick et al.
JOURNAL OF NEUROSURGERY (2006)
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors
IK Mellinghoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Redistribution of aquaporin-4 in human glioblastoma correlates with loss of agrin immunoreactivity from brain capillary basal laminae
A Warth et al.
ACTA NEUROPATHOLOGICA (2004)
Molecular mechanisms of brain tumor edema
MC Papadopoulos et al.
NEUROSCIENCE (2004)
The effect of O6-alkylguanine-DNA alkyltransferase and mismatch repair activities on the sensitivity of human melanoma cells to temozolomide, 1,3-bis(2-chloroethyl)-1-nitrosourea, and cisplatin
R Pepponi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Mechanisms of carcinogenicity/chemotherapy by O6-methylguanine
GP Margison et al.
MUTAGENESIS (2002)
Blood-brain barrier breakdown in septic encephalopathy and brain tumours
DC Davies
JOURNAL OF ANATOMY (2002)
Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme
S Liebner et al.
ACTA NEUROPATHOLOGICA (2000)
分享论文
